Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
NCT ID: NCT02488746
Last Updated: 2016-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
5 participants
OBSERVATIONAL
2015-03-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EFTR-GERDX
Endoscopic full thickness resection of subepithelial gastric tumors using the GERDX suturing device.
GERDX(TM)
Endoscopic full thickness resection of subepithelial gastric tumors using the GERDX suturing device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GERDX(TM)
Endoscopic full thickness resection of subepithelial gastric tumors using the GERDX suturing device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 years or older
* participant has given informed consent
Exclusion Criteria
* signs of systemic dissemination of tumor
* current presence of a different neoplastic disease (except after successful curative treatment without continued medication)
* former surgery or disease of esophagus or stomach that impedes insertion of the suturing device
* moribund patient
* limited possibility to give informed consent (e.g. language barrier, psychiatric disease)
* pregnancy and lactation period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kliniken Ludwigsburg-Bietigheim gGmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karel Caca, Prof. Dr.
Role: STUDY_CHAIR
Klinikum Ludwigsburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Ludwigsburg
Ludwigsburg, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FROST
Identifier Type: -
Identifier Source: org_study_id